Invasive Streptococcus anginosus group infection-does the species predict the outcome?

被引:36
作者
Junckerstorff, Ralph K. [1 ,2 ]
Robinson, J. Owen [3 ,5 ]
Murray, Ronan J. [1 ,4 ]
机构
[1] Sir Charles Gairdner Hosp, Dept Infect Dis, Perth, WA 6000, Australia
[2] Monash Med Ctr, Melbourne, Vic 3168, Australia
[3] Royal Perth Hosp, PathWest Lab Med WA, Dept Microbiol & Infect Dis, Perth, WA 6001, Australia
[4] Queen Elizabeth II Med Ctr, PathWest Lab Med WA, Dept Microbiol, Perth, WA, Australia
[5] Curtin Univ, Sch Biomed Sci, Australian Collaborating Ctr Enterococcus & Staph, Perth, WA, Australia
关键词
Streptococcus anginosus; Streptococcus constellatus; Streptococcus intermedius; Mortality; Length of stay; MILLERI GROUP; ANTIMICROBIAL SUSCEPTIBILITY; CONSTELLATUS; INTERMEDIUS; BACTEREMIA; PREVALENCE; SCORE;
D O I
10.1016/j.ijid.2013.09.003
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: To determine whether there is an association between the species of Streptococcus anginosus group (SAG) bacteria and the clinical outcome. Methods: Isolates from invasive infections caused by SAG bacteria at our institution between January 2004 and February 2009 were identified phenotypically to the taxonomic level of species. Clinical data from the medical records of the patients from whom these isolates were recovered were obtained retrospectively and analyzed. Results: Patients with invasive Streptococcus intermedius infections had a significantly longer hospital stay than patients infected with S. anginosus (p = 0.024) and a significantly higher 30-day all-cause mortality than patients infected with Streptococcus constellatus (p = 0.049). Conclusion: Identification of SAG bacteria to the taxonomic level of species may be of prognostic importance. (C) 2013 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. All rights reserved.
引用
收藏
页码:38 / 40
页数:3
相关论文
共 14 条
[1]   Prevalence of erythromycin and clindamycin resistance among clinical isolates of the Streptococcus anginosus group in Germany [J].
Asmah, Nadine ;
Eberspaecher, Bettina ;
Regnath, Thomas ;
Arvand, Mardjan .
JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 58 (02) :222-227
[2]   Species belonging to the ''Streptococcus milleri'' group: Antimicrobial susceptibility and comparative prevalence in significant clinical specimens [J].
Bantar, C ;
Canigia, LF ;
Relloso, S ;
Lanza, A ;
Bianchini, H ;
Smayevsky, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (08) :2020-2022
[3]   Prospective study of Streptococcus milleri bacteremia [J].
Casariego, E ;
Rodriguez, A ;
Corredoira, JC ;
Alonso, P ;
Coira, A ;
Bal, M ;
Lopez, MJ ;
Varela, J .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (03) :194-200
[4]   Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus ("Streptococcus milleri group") are of different clinical importance and are not equally associated with abscess [J].
Clarridge, JE ;
Attorri, S ;
Musher, DM ;
Hebert, J ;
Dunbar, S .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (10) :1511-1515
[5]   BACTERIOLOGICAL CHARACTERISTICS AND ANTIMICROBIAL SUSCEPTIBILITY OF 70 CLINICALLY SIGNIFICANT ISOLATES OF STREPTOCOCCUS-MILLERI GROUP [J].
GOMEZGARCES, JL ;
ALOS, JI ;
COGOLLOS, R .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1994, 19 (02) :69-73
[6]  
GOSSLING J, 1988, REV INFECT DIS, V10, P257
[7]   An electronic application for rapidly calculating Charlson comorbidity score [J].
Hall, WH ;
Ramachandran, R ;
Narayan, S ;
Jani, AB ;
Vijayakumar, S .
BMC CANCER, 2004, 4 (1)
[8]   BACTEREMIA INVOLVING THE STREPTOCOCCUS-MILLERI GROUP - ANALYSIS OF 19 CASES [J].
JACOBS, JA ;
PIETERSEN, HG ;
STOBBERINGH, EE ;
SOETERS, PB .
CLINICAL INFECTIOUS DISEASES, 1994, 19 (04) :704-713
[9]  
JACOBS JA, 1995, AM J CLIN PATHOL, V104, P547
[10]   A NEW SIMPLIFIED ACUTE PHYSIOLOGY SCORE (SAPS-II) BASED ON A EUROPEAN NORTH-AMERICAN MULTICENTER STUDY [J].
LEGALL, JR ;
LEMESHOW, S ;
SAULNIER, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (24) :2957-2963